ResMed
RMD79
$251.77arrow_drop_up1.14%$2.84
High Quality
S&P500
RMD79
$251.77
arrow_drop_up1.14%| Key Stats | |
|---|---|
| Open | $249.75 |
| Prev. Close | $248.92 |
| EPS | 6.92 |
| Next Earnings Date | Dec 26, 2024 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 248.75 | 252.91 |
| 52 Week Range | 132.24 | 255.17 |
| Ratios | |
|---|---|
| EPS | 6.92 |
| Fundamentals | |
|---|---|
| Industry average yield | 2.96% |
| Last Dividend pay date | Sep 19, 2024 |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
RMD-
US Healthcare Sector-
US Market-
warning
RMD / Market
RMD lose to the US Market which returned -0.09% over the last twenty four hours.warning
RMD / Healthcare Sector
RMD lose to the US Healthcare sector which returned 0.72% over the last twenty four hours.ResMed (RMD) Statistics
Keep an eye on ResMed
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has ResMed (RMD) stock's performance compared to its sector and the market over the past year?
Over the past year, ResMed (RMD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.31%, ResMed has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 63.77%, it has fallen short of the market average. This comparison highlights ResMed 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of ResMed (RMD) stock?
The PE (Price to Earnings) ratio of ResMed (RMD) is currently 36.38. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of ResMed (RMD) stock?
The Earnings Per Share (EPS) for ResMed (RMD), calculated on a diluted basis, is $6.92. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of ResMed (RMD) stock?
The operating margin for ResMed (RMD) is 31.17%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of ResMed (RMD) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of ResMed (RMD) is $1.59B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does ResMed (RMD) have?
ResMed (RMD) has a total debt of $873.93M. The net debt, which accounts for cash and cash equivalents against the total debt, is $635.57M.